Quarterly results
Q2 2010
Q2 2010 results - July 15, 2010
| Q2 2010 (USD m) | Q2 2009 (USD m) | % change (USD/cc1) | |
|---|---|---|---|
| Net sales | 11 716 | 10 546 | 11 (cc: 12) |
| Operating income | 2 961 | 2 364 | 25 (cc: 24) |
| Net income | 2 437 | 2 044 | 19 (cc: 18) |
| EPS (USD) | 1.06 | 0.90 | 18 (cc: 17) |
| Free cash flow (before dividends) | 2 368 | 1 916 | 24 |
Core2 | |||
| Operating income | 3 276 | 2 663 | 23 (cc: 23) |
| Net income | 2 771 | 2 394 | 16 (cc: 15) |
| EPS (USD) | 1.20 | 1.05 | 14 (cc: 14) |
1 Constant currencies
2 Core results for operating income, net income and earnings per share (EPS) eliminate the amortization of intangible assets, the impact of acquisition-related factors and other significant exceptional items. See media release for further information.
View archived presentations and webcasts from past events
The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Corporate publications
Download our latest financial reports.
Form 20-F 2009
(1.3 MB)
2010 key events
Jan 26 - Fourth quarter and full-year 2009 results
Feb 26 - Annual General Meeting
Apr 20 - First quarter 2010 results
Jul 15 - Second quarter and first half 2010 results
Oct 21 - Third quarter and first nine months 2010 results
